The Forsyth Institute
17
0
0
15
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
5.9%
1 terminated/withdrawn out of 17 trials
93.8%
+7.2% vs industry average
12%
2 trials in Phase 3/4
27%
4 of 15 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (17)
Phase 2 Study of KH001 in Long-term Relief From Dentin Hypersensitivity
Role: collaborator
Commensal Oral Microbiota in Head and Neck Cancer
Role: collaborator
Optical Coherence Tomography (OCT) Based Intraoral Scanner
Role: collaborator
Menopause and Oral Microbiome
Role: collaborator
Safety and Preliminary Efficacy of Lipoxin Analog BLXA4-ME Oral Rinse for the Treatment of Gingivitis
Role: lead
DENTAL GUM TISSUE AGING
Role: lead
The Effect of Silver Diamine Fluoride (SDF) on Bacteria Involved in Root or Cervical Carious Lesions
Role: collaborator
Biomarkers of Periodontal Disease Progression
Role: lead
Reproducibility of HbA1c Measurement on the Aina HbA1c Monitoring System
Role: collaborator
Randomized Trial of a Gum Health Formulation
Role: collaborator
Salivary Bacterial Associations to Short Term Discontinuation of Self-performed Oral Hygiene
Role: collaborator
Salivary Bacterial Profiles in Relation to Periodontal Treatment
Role: collaborator
Effect of Three Periodontal Therapies in Current Smokers and Non-Smokers
Role: lead
LGG/BB12-pastille Study
Role: collaborator
Study Comparing Two Different Methods of Treating Periodontal Disease
Role: lead
Microbial Associations in Periodontal Health and Disease
Role: lead
Control of Periodontal Infections
Role: lead
All 17 trials loaded